1.Reoperation Versus Dose-Escalated Radiotherapy for Ductal Carcinoma In Situ at the Surgical Margin After Breast-Conserving Surgery for Invasive Ductal Carcinoma
Bombi PARK ; SunHyung CHOI ; Jaihong HAN ; So-Youn JUNG ; Seeyoun LEE ; Han-Sung KANG ; Sinae KIM ; Youngmee KWON ; Eun-Gyeong LEE
Journal of Breast Cancer 2025;28(6):381-392
Purpose:
The aim of this study was to compare local recurrence (LR) rates in patients with ductal carcinoma in situ (DCIS) at the surgical margins after breast-conserving surgery (BCS).
Methods:
This single-center, retrospective study included patients diagnosed with invasive ductal carcinoma (IDC) who underwent BCS at National Cancer Center between 2014 and 2020. Patients with DCIS at the surgical margin were eligible for inclusion. Those who did not undergo re-excision received whole-breast radiotherapy with an escalated tumor bed boost of 15 Gy in five fractions. The 5-year breast cancer recurrence rates were estimated using the Kaplan-Meier method, and prognostic factors were evaluated using univariate and multivariate Cox proportional hazards regression models.
Results:
Among the 235 eligible patients, 115 underwent re-excision (Re-excision + group), and 120 did not (Re-excision − group). With a median follow-up of 5.0 years (range, 3.1–6.6 years), the 5-year LR rate was 6.1% in the Re-excision + group and 5.8% in the Re-excision − group (log-rank p = 0.9). Re-excision was not significantly associated with differences in LR rates in multivariate analysis.
Conclusion
In cases where DCIS was present at the surgical margin after BCS, re-excision was not associated with a lower LR rate compared with dose-escalated radiotherapy.This study did not assess late radiation-related toxicities, such as breast fibrosis, which are important considerations for treatment decision-making. These findings should be interpreted with caution because of the retrospective design and limited event rate. Further prospective studies are warranted to determine optimal management strategies.
2.Anaphylaxis to lansoprazole with tolerance to other proton pump inhibitors.
In Young PARK ; Byung Joo DO ; Jae Sung AHN ; Jae Hyuk LEE ; Gye Yeon LEE ; Sunhyung KIM ; Jeong Hee CHOI
Allergy, Asthma & Respiratory Disease 2014;2(5):383-386
Anaphylaxis to proton pump inhibitors (PPIs) has rarely been reported. Different patterns of cross-reactivity between PPIs have also been demonstrated using skin tests. Here, we report a case of anaphylaxis to lansoprazole with tolerance to other commercially available PPIs, which was proved by skin tests and oral provocation tests (OPTs). A 47-year-old female patient visited our Emergency Department with a sudden onset of whole body urticaria, facial swelling, dyspnea, and loss of consciousness that developed 1 hour after ingestion of 30 mg of lansoprazole for her episodic epigastric soreness. The skin prick test (SPT) and the intradermal test (IDT) with lansoprazole, esomeprazole, rabeprazole, and pantoprazole were performed. Lansoprazole showed positive reactions in both the SPT (3 mg/mL) and the IDT (0.003 mg/mL). Rabeprazole (3 mg/mL) showed a positive reaction only in IDT. The SPT and the IDT with esomeprazole and pantoprazole were all negative. The OPT with 30 mg of lansoprazole was positive (showing generalized rash and facial swelling 30 minuites after ingestion), while OPTs with esomeprazole, pantoprazole, and rabeprazole were all negative. Other PPIs could be safe alternatives in cases of anaphylaxis to 1 PPI. Skin tests seem to be helpful to define cross-reactivity between PPIs.
Anaphylaxis*
;
Dyspnea
;
Eating
;
Emergency Service, Hospital
;
Esomeprazole
;
Exanthema
;
Female
;
Humans
;
Intradermal Tests
;
Lansoprazole*
;
Middle Aged
;
Proton Pump Inhibitors*
;
Rabeprazole
;
Skin
;
Skin Tests
;
Unconsciousness
;
Urticaria
3.Cyclooxygenase (COX)-1, Cyclooxygenase (COX)-2 and E-cadherin Expression in Colorectal Cancer Patients with Hepatic Metastasis.
Sun Hyung JOO ; Bum Soo KIM ; Sung Il CHOI ; Jeong Yoon SONG ; Kil Yeon LEE ; Yun Wha KIM ; Gyo Young KIM ; Suk Hwan LEE ; Sang Mok LEE ; Sung Wha HONG
Journal of the Korean Surgical Society 2010;78(3):177-183
PURPOSE: Recent studies have shown that cyclooxygenase (COX)-2 may be involved in colorectal carcinogenesis. In this study, we evaluate the differences of COX-2 expression in patients with synchronous and metachronous hepatic metastasis of colorectal cancer. In addition, the expression of COX-1 and E-cadherin were also evaluated. METHODS: Paraffin embedded blocks were obtained from 41 patients who underwent surgery for colorectal cancer with hepatic metastasis. Samples from primary colorectal cancer, synchronous and metachronous hepatic lesions were stained by immunohistochemistry for monoclonal antibody against COX-1, COX-2, and E-cadherin. RESULTS: In colonic COX-1 expression, there was no significant difference in the degree of COX-1 expression between primary colorectal cancer with synchronous hepatic metastasis and that of metachronous hepatic metastasis (P=0.507). In colonic COX-2 and E-cadherin expression, the degree of COX-2 expression was not different between the two groups. But, the patient survival rate in the positive group of COX-1 and COX-2 expression was lower than in the negative group, respectively (P=0.023, P=0.006). CONCLUSION: The degree of colonic COX-1 and COX-2 expression has an impact on prognosis in synchronous and metachronous hepatic metastasis. Further large-scale study is necessary to determine the meaning of COX-2 expression in colorectal cancer.
Cadherins
;
Colon
;
Colorectal Neoplasms
;
Humans
;
Immunohistochemistry
;
Neoplasm Metastasis
;
Paraffin
;
Prognosis
;
Prostaglandin-Endoperoxide Synthases
;
Survival Rate
4.Agenesis of the Gallbladder.
Sun Hyung JOO ; Bum Soo KIM ; Sung Il CHOI ; Kwang Ro JOO ; Eun Hee YOO
Journal of the Korean Surgical Society 2008;75(5):351-354
Gallbladder agenesis is a rare congenital biliary anomaly that may be associated with other biliary and extrabiliary congenital anomalies. Awareness of this condition is important because many of these patients may have vague biliary symptoms that lead to unnecessary operations. We treated a 46-year-old woman who was diagnosed with gallbladder agenesis during performance of gynecologic laparoscopic surgery. The gallbladder was not visualized by the preoperative abdominal ultrasonography, the abdominal computed tomography and the MRCP. The hepatobiliary scan revealed non-visualization of the gallbladder. Based on these imaging studies, there was a high suspicion of a sclero-atrophic gallbladder or agenesis of the gallbladder. At surgery, we carefully examined the porta hepatis and found that the gallbladder was absent. The operation involved only examination with a laparoscope. The patient has remained well and asymptomatic. It is extremely difficult to diagnose gallbladder agenesis in clinical settings; the identification of gallbladder agenesis is often an incidental finding. For cases where the gallbladder is not visualized preoperatively, a diagnostic laparoscopy can be an alternative diagnostic tool prior to performing laparotomy.
Female
;
Gallbladder
;
Humans
;
Incidental Findings
;
Laparoscopes
;
Laparoscopy
;
Laparotomy
;
Middle Aged

Result Analysis
Print
Save
E-mail